BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9393598)

  • 21. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells.
    Scott LM; Civin CI; Rorth P; Friedman AD
    Blood; 1992 Oct; 80(7):1725-35. PubMed ID: 1391942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular, cytogenetic and genetic abnormalities in MDS and secondary AML.
    Padua RA; McGlynn A; McGlynn H
    Cancer Treat Res; 2001; 108():111-57. PubMed ID: 11702597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas.
    Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
    Med Pediatr Oncol; 2001 Jan; 36(1):42-4. PubMed ID: 11464902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.
    Puda A; Milosevic JD; Berg T; Klampfl T; Harutyunyan AS; Gisslinger B; Rumi E; Pietra D; Malcovati L; Elena C; Doubek M; Steurer M; Tosic N; Pavlovic S; Guglielmelli P; Pieri L; Vannucchi AM; Gisslinger H; Cazzola M; Kralovics R
    Am J Hematol; 2012 Mar; 87(3):245-50. PubMed ID: 22190018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional evidence from microcell-mediated chromosome transfer of myeloid leukemia suppressor genes on human chromosomes 7 and 11.
    Wilding J; Meijne E; Haines J; Moody J; Edwards A; Newbold RF; Parris C; Cox R; Silver A
    Genes Chromosomes Cancer; 2002 Aug; 34(4):390-7. PubMed ID: 12112528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p.
    Mori N; Morosetti R; Mizoguchi H; Koeffler HP
    Br J Haematol; 2003 Jul; 122(2):226-30. PubMed ID: 12846890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
    Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a highly complex region in Xq13 and mapping of three isodicentric breakpoints associated with preleukemia.
    McDonell N; Ramser J; Francis F; Vinet MC; Rider S; Sudbrak R; Riesselman L; Yaspo ML; Reinhardt R; Monaco AP; Ross F; Kahn A; Kearney L; Buckle V; Chelly J
    Genomics; 2000 Mar; 64(3):221-9. PubMed ID: 10756090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
    Sinclair P; Harrison CJ; Jarosová M; Foroni L
    Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
    Stephenson J; Czepulkowski B; Hirst W; Mufti GJ
    Leuk Res; 1996 Mar; 20(3):235-41. PubMed ID: 8637218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation.
    Kawano S; Miller CW; Gombart AF; Bartram CR; Matsuo Y; Asou H; Sakashita A; Said J; Tatsumi E; Koeffler HP
    Blood; 1999 Aug; 94(3):1113-20. PubMed ID: 10419905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
    Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
    Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human C/EBP delta (CRP3/CELF) gene: structure and chromosomal localization.
    Cleutjens CB; van Eekelen CC; van Dekken H; Smit EM; Hagemeijer A; Wagner MJ; Wells DE; Trapman J
    Genomics; 1993 May; 16(2):520-3. PubMed ID: 8314590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia.
    Johan MF; Bowen DT; Frew ME; Goodeve AC; Reilly JT
    Br J Haematol; 2005 Apr; 129(1):60-5. PubMed ID: 15801956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of loss of heterozygosity with cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome.
    Pinheiro RF; Serio FM; Silva MR; Briones MR; Chauffaille ML
    Braz J Med Biol Res; 2008 Jul; 41(7):610-4. PubMed ID: 18719743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome.
    Iwai M; Kiyoi H; Ozeki K; Kinoshita T; Emi N; Ohno R; Naoe T
    Leukemia; 2005 Aug; 19(8):1367-75. PubMed ID: 15902282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allelic loss on chromosome 4 (Lyr2/TLSR5) is associated with myeloid, B-lympho-myeloid, and lymphoid (B and T) mouse radiation-induced leukemias.
    Cleary H; Boulton E; Plumb M
    Blood; 2001 Sep; 98(5):1549-54. PubMed ID: 11520806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.